Clinical characteristics of recurrent esophageal cancer after definitive chemoradiotherapy for stage II/III (non T4) esophageal squamous cell cancer

被引:1
|
作者
Nishikawa, Akiko
Kato, Ken
Honma, Yoshitaka
Iwasa, Satoru
Takashima, Atsuo
Hamaguchi, Tetsuya
Yamada, Yasuhida
Shimada, Yasuhiro
机构
[1] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan
关键词
D O I
10.1200/jco.2013.31.4_suppl.137
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
137
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Prospective study of definitive chemoradiotherapy with S-1 and nedaplatin in patients with stage II/III (non-T4) esophageal cancer
    Takashi Tsuda
    Hiroyuki Inaba
    Aya Miyazaki
    Naoki Izawa
    Mami Hirakawa
    Yoshiyuki Watanabe
    Satoshi Kitajima
    Yoshikazu Hoshikawa
    Hiromichi Gomi
    Masayuki Kimura
    Fumio Itoh
    Esophagus, 2011, 8 : 45 - 51
  • [12] Prospective study of definitive chemoradiotherapy with S-1 and nedaplatin in patients with stage II/III (non-T4) esophageal cancer
    Tsuda, Takashi
    Inaba, Hiroyuki
    Miyazaki, Aya
    Izawa, Naoki
    Hirakawa, Mami
    Watanabe, Yoshiyuki
    Kitajima, Satoshi
    Hoshikawa, Yoshikazu
    Gomi, Hiromichi
    Kimura, Masayuki
    Itoh, Fumio
    ESOPHAGUS, 2011, 8 (01) : 45 - 51
  • [13] Endoscopic resection for local residual or recurrent cancer after definitive chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
    Tani, Yasuhiro
    Ishihara, Ryu
    Matsuura, Noriko
    Okubo, Yuki
    Kawakami, Yushi
    Sakurai, Hirohisa
    Nakamura, Takahiko
    Matsueda, Katsunori
    Miyake, Muneaki
    Shichijo, Satoki
    Maekawa, Akira
    Kanesaka, Takashi
    Yamamoto, Sachiko
    Takeuchi, Yoji
    Higashino, Koji
    Uedo, Noriya
    Michida, Tomoki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [14] Endoscopic resection for local residual or recurrent cancer after definitive chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
    Yasuhiro Tani
    Ryu Ishihara
    Noriko Matsuura
    Yuki Okubo
    Yushi Kawakami
    Hirohisa Sakurai
    Takahiko Nakamura
    Katsunori Matsueda
    Muneaki Miyake
    Satoki Shichijo
    Akira Maekawa
    Takashi Kanesaka
    Sachiko Yamamoto
    Yoji Takeuchi
    Koji Higashino
    Noriya Uedo
    Tomoki Michida
    Scientific Reports, 13
  • [15] Chemoradiotherapy and surgery for T4 esophageal cancer in Japan
    Akutsu, Yasunori
    Matsubara, Hisahiro
    SURGERY TODAY, 2015, 45 (11) : 1360 - 1365
  • [16] Chemoradiotherapy and surgery for T4 esophageal cancer in Japan
    Yasunori Akutsu
    Hisahiro Matsubara
    Surgery Today, 2015, 45 : 1360 - 1365
  • [17] Neoadjuvant Chemoradiotherapy for Clinical Stage II-III Esophageal Squamous Cell Carcinoma
    Saeki, Hiroshi
    Morita, Masaru
    Nakashima, Yuichiro
    Sonoda, Hideto
    Hashimoto, Kenkichi
    Egashira, Akinori
    Oki, Eiji
    Ohga, Takefumi
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2011, 31 (09) : 3073 - 3077
  • [18] Patterns of local-regional relapse after complete response by definitive chemoradiotherapy for stage II/III (non-T4) esophageal squamous cell carcinoma.
    Sudo, Kazuki
    Kato, Ken
    Kuwabara, Hiroki
    Sasaki, Yusuke
    Takahashi, Naoki
    Shoji, Hirokazu
    Iwasa, Satoru
    Honma, Yoshitaka
    Okita, Natsuko T.
    Takashima, Atsuo
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [19] Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma Discussion
    Sugarbaker, David J.
    Molena, Daniela
    Swanson, Scott
    Decamp, Malcolm M.
    Weksler, Benny
    Lerut, Toni
    Chen, Ke-Neng
    Yang, Haoxian
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2719 - +
  • [20] Definitive Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Matter of Standard Reply
    Zhao, Kuaile
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (26) : 2380 - +